Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2), the pathogen of the
Coronavirus disease-19 (COVID-19), is still devastating the world causing significant chaos …

The worldwide spreading of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐
2) has posed a serious threat to health, economic, environmental, and social aspects of …

Severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) is the virus that causes
COVID-19 which is responsible for respiratory illness infection in humans. The virus was first …

Abstract SARS-CoV-2 papain-like protease (PLpro) covers multiple functions. Beside the
cysteine-protease activity, facilitating cleavage of the viral polypeptide chain, PLpro has the …

Since the number of drugs based on natural products (NPs) represents a large source of
novel pharmacological entities, NPs have acquired significance in drug discovery. Peru is …

Phytochemical-based drug discovery against the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) has been the focus of the current scenario. In this context, we …

Over 750 million cases of COVID-19, caused by the Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2), have been reported since the onset of the global outbreak …

The ongoing COVID-19 pandemic has resulted in a global panic because of its continual
evolution and recurring spikes. This serious malignancy is caused by the severe acute …

Abstract Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is considered
the etiological agent of the disease that caused the COVID-19 pandemic, and for which …

Introduction: Leishmaniasis is a disease with high mortality rates and approximately 1.5
million new cases each year. Despite the new approaches and advances to fight the …